Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Blog

Home Archive by category "Featured Stories"

Precautions for the selection of immunofluorescence double-labeled antibodies

By medicilon | Featured Stories | Comments are Closed | 19 February, 2021 |

Double immunofluorescence When detecting two antigens at the same time in the same tissue or cell sample, double fluorescent staining is required. Double immunofluorescence labeling method (double immunofluorescence labeling method) is also divided into direct method and indirect method. Direct double immunofluorescence labeling Direct double immunofluorescence labeling: mix two different fluorescein-labeled antibodies (such as anti-ARead more

Fluorescein FITC-labeled antibody method

By medicilon | Featured Stories | Comments are Closed | 19 February, 2021 |

Immunofluorescence technology combines fluorescein such as fluorescein isothiocyanate (FITC) with the corresponding antibody (or antigen) in a chemical way, and combines the fluorescent-labeled antibody (or antigen) with the corresponding antigen in the specimen to form a fluorescent-labeled antibody -Antigen complex, observe with a fluorescence microscope. The presence of fluorescence under the microscope indicates the presenceRead more

Application of fluorescent antibody in clinical diagnosis and treatment

By medicilon | Featured Stories | Comments are Closed | 19 February, 2021 |

Autoimmune disease refers to a series of pathological immune responses produced by the body’s immune effect or immune effector molecules against one’s own tissues or cells, leading to a large class of diseases that damage their own tissues and organs. The pathogenesis is very complex and the clinical manifestations are variable. , Often involving theRead more

Fluorescent Antibody Technique

By medicilon | Featured Stories | Comments are Closed | 19 February, 2021 |

Fluorescence immunoassay technology is one of the earliest developed labeling immunoassay techniques. For a long time, some scholars have tried to combine antibody molecules with some tracer substances, and use antigen-antibody reaction to locate antigenic substances in tissues or cells. Coons was equal to the first successful use of fluorescein for labeling in 1941. ThisRead more

Analysis on the role of drug dissolution test in the determination of human bioavailability

By medicilon | Featured Stories | Comments are Closed | 18 February, 2021 |

The dissolution rate and extent of solid preparations such as tablets, capsules, or granules in a prescribed medium refer to the dissolution rate of the drug. Since the dissolution of the drug will directly affect the absorption and utilization of the drug in the body, the drug dissolution test is an important indicator to evaluateRead more

Humanization of antibody reduces the immunogenicity of antibody drugs

By medicilon | Featured Stories | Comments are Closed | 18 February, 2021 |

The application of antibodies has a history of hundreds of years. As a disease prevention, diagnosis and treatment agent, antibody drugs have undergone the development of murine antibodies, chimeric antibodies, humanized antibodies and fully humanized antibodies. Because the antibody drug is a kind of foreign protein, it is easy to activate the body’s own immuneRead more

Analysis on the method of immunogenicity detection of biotechnology drugs

By medicilon | Featured Stories | Comments are Closed | 18 February, 2021 |

Immunogenicity refers to the nature of drugs that stimulate the body to form specific antibodies or sensitized lymphocytes. In the development of biotechnology drugs, immunogenicity testing is an important task. For patients, immunogenicity will affect the safety and effectiveness of drugs, and even cause life-threatening dangers to patients because of the crossover of anti-drug antibodiesRead more

You have never heard of the protein that can “melt” tumors!

By medicilon | Featured Stories | Comments are Closed | 18 February, 2021 |

Recently, cancer researchers at Vanderbilt discovered a new protein that, when genetically regulated to prevent it from interacting with the genes responsible for cancer, will effectively melt tumors within a few days. This exciting research result was recently published in eLife magazine. protein that can melt tumors You have never heard of the protein thatRead more

Analysis of the potential target of lung cancer treatment-aquaporin 4

By medicilon | Featured Stories | Comments are Closed | 9 February, 2021 |

Lung cancer is one of the most harmful malignant tumors. To explore the pathogenesis of lung cancer and to find new targets for anti-tumor therapy are the hotspots and difficulties of current lung cancer treatment research. Studies have found that aquaporin 4 (AQP4) is highly expressed in lung cancer cells, and knocking down AQP4 canRead more

Analysis on the Role of Cytokine Detection in the Evaluation of Drug Treatment Effect

By medicilon | Featured Stories | Comments are Closed | 9 February, 2021 |

Cytokines that can regulate the physiological functions of a variety of cells are small molecular protein substances with biological activity secreted by cells. The concentration of cytokines and their receptors can reflect the pathological process of the disease. Through the detection of cytokines and the detection of the level of soluble receptors, the effects ofRead more

1234

About Us

  • Medicilon Overview
  • Executive Team
  • Company History
  • CEO Message
  • Honor
  • Customer Reviews
  • New Models of Collaboration
  • Intellectual Property Protection
  • Corporate Culture
  • Careers
  • Download Center
  • Contact

Share

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc